Literature DB >> 32311291

Update in Pulmonary Vascular Diseases and Right Ventricular Dysfunction 2019.

Elena A Goncharova1,2, Stephen Y Chan1,3,4,5, Corey E Ventetuolo5,6, Norbert Weissmann7, Ralph T Schermuly7, Christopher J Mullin5, Mark T Gladwin1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32311291      PMCID： PMC7328315          DOI： 10.1164/rccm.202003-0576UP

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  87 in total

1.  Right Ventricular Fibrosis Is Related to Pulmonary Artery Stiffness in Pulmonary Hypertension: A Cardiac Magnetic Resonance Imaging Study.

Authors:  Matthew Jankowich; Siddique A Abbasi; Alexander Vang; Gaurav Choudhary
Journal:  Am J Respir Crit Care Med       Date:  2019-09-15       Impact factor: 21.405

2.  Lessons from Transcriptomics in Hypoxia-induced Pulmonary Hypertension: Does the Mouse Strain Matter?

Authors:  Leigh M Marsh; Grazyna Kwapiszewska
Journal:  Am J Respir Cell Mol Biol       Date:  2019-01       Impact factor: 6.914

3.  An RNA Sensor Protects against Pulmonary Hypertension.

Authors:  Gabriele Grunig; Nedim Durmus
Journal:  Am J Respir Crit Care Med       Date:  2019-01-15       Impact factor: 21.405

4.  Mild Elevation of Pulmonary Arterial Pressure as a Predictor of Mortality.

Authors:  Philipp Douschan; Gabor Kovacs; Alexander Avian; Vasile Foris; Fabian Gruber; Andrea Olschewski; Horst Olschewski
Journal:  Am J Respir Crit Care Med       Date:  2018-02-15       Impact factor: 21.405

5.  Transplantation of Mesenchymal Stem Cells Attenuates Pulmonary Hypertension by Normalizing the Endothelial-to-Mesenchymal Transition.

Authors:  Junyi Huang; Wenju Lu; Haiping Ouyang; Yuqin Chen; Chenting Zhang; Xiaoyun Luo; Meichan Li; Jiaze Shu; Qiuyu Zheng; Haixia Chen; Jiyuan Chen; Haiyang Tang; Dejun Sun; Jason X-J Yuan; Kai Yang; Jian Wang
Journal:  Am J Respir Cell Mol Biol       Date:  2020-01       Impact factor: 6.914

6.  Targeting cyclin-dependent kinases for the treatment of pulmonary arterial hypertension.

Authors:  Astrid Weiss; Moritz Christian Neubauer; Dinesh Yerabolu; Baktybek Kojonazarov; Beate Christiane Schlueter; Lavinia Neubert; Danny Jonigk; Nelli Baal; Clemens Ruppert; Peter Dorfmuller; Soni Savai Pullamsetti; Norbert Weissmann; Hossein-Ardeschir Ghofrani; Friedrich Grimminger; Werner Seeger; Ralph Theo Schermuly
Journal:  Nat Commun       Date:  2019-05-17       Impact factor: 14.919

7.  Myocardial Fibrosis as a Potential Maladaptive Feature of Right Ventricle Remodeling in Pulmonary Hypertension.

Authors:  Catherine E Simpson; Paul M Hassoun
Journal:  Am J Respir Crit Care Med       Date:  2019-09-15       Impact factor: 21.405

8.  Emphysema Is-at the Most-Only a Mild Phenotype in the Sugen/Hypoxia Rat Model of Pulmonary Arterial Hypertension.

Authors:  Harm J Bogaard; Ekaterina Legchenko; Ketul R Chaudhary; Xiao-Qing Sun; Duncan J Stewart; Georg Hansmann
Journal:  Am J Respir Crit Care Med       Date:  2019-12-01       Impact factor: 21.405

9.  Cardiopulmonary Impact of Hypoxic Ischemic Encephalopathy in Newborn Infants. The Emerging Role of Early Hemodynamic Assessment in Determining Adverse Neurological Outcomes.

Authors:  Gabriel Altit; Philip T Levy
Journal:  Am J Respir Crit Care Med       Date:  2019-11-15       Impact factor: 21.405

10.  Is Myocardial Fibrosis Impairing Right Heart Function?

Authors:  Harm Jan Bogaard; Norbert F Voelkel
Journal:  Am J Respir Crit Care Med       Date:  2019-06-15       Impact factor: 21.405
View more
  2 in total

1.  Mechanosensitive channel Piezo1 is required for pulmonary artery smooth muscle cell proliferation.

Authors:  Jiyuan Chen; Marisela Rodriguez; Jinrui Miao; Jing Liao; Pritesh P Jain; Manjia Zhao; Tengteng Zhao; Aleksandra Babicheva; Ziyi Wang; Sophia Parmisano; Ryan Powers; Moreen Matti; Cole Paquin; Zahra Soroureddin; John Y-J Shyy; Patricia A Thistlethwaite; Ayako Makino; Jian Wang; Jason X-J Yuan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2022-03-23       Impact factor: 6.011

Review 2.  mTOR Signaling in Pulmonary Vascular Disease: Pathogenic Role and Therapeutic Target.

Authors:  Aleksandra Babicheva; Ayako Makino; Jason X-J Yuan
Journal:  Int J Mol Sci       Date:  2021-02-21       Impact factor: 5.923
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.